Scemblix 40 MG tablet UU 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F5BGR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,956
Award facts
- Contract value 100% obligated
- $15,956.33 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $15,956.33 delivery order to Amerisourcebergen Drug Corp on May 8, 2026, for SCEMBLIX 40 mg tablets (60-count units), with an ultimate completion date of June 1, 2026.
Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside. Amerisourcebergen Drug Corp operates as a pharmaceutical distributor and medical supplier delivering brand-name and generic medications, specialty pharmaceuticals, vaccines, and medical devices to the Department of Defense and federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F5BGR?
SPE2DR26F5BGR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 8, 2026.
How much is contract SPE2DR26F5BGR worth?
The government has obligated $15,956 on SPE2DR26F5BGR.
Is contract SPE2DR26F5BGR an order under another contract?
Yes. SPE2DR26F5BGR is a delivery order under SPE2DR25D2010, an indefinite delivery contract.
Was contract SPE2DR26F5BGR competed?
The extent of competition for SPE2DR26F5BGR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award